CD4 binding-site antibodies induced by a subtype B HIV-1 envelope trimer
Schorcht, A.; van den Kerkhof, T. L. G. M.; Torres, J.; Schermer, E.; LaBranche, C.; Bontjer, I.; Brinkkemper, M.; Gulzar, N.; Han, A. X.; Burger, J.; Ozorowski, G.; Scott, J.; Schuitemaker, H.; Montefiori, D.; van Gils, M.; Ward, A. B.; Sanders, R. W.
Show abstract
In the last decade considerable advances have been made towards the design of HIV-1 vaccines that induce neutralizing antibodies (NAbs). Despite the progress, no vaccine is able to consistently elicited broadly neutralizing antibodies (bNAbs). Here we present a case study of a rabbit that was immunized with a subtype B native like envelope glycoprotein (Env) trimer, AMC016 SOSIP.v4.2, with a dense and intact glycan shield, followed by a trivalent combination of subtype B trimers. After the priming phase serum from this animal neutralized several heterologous subtype B neutralization resistant (tier 2) viruses. Subsequent immunization with the trivalent combination of subtype B trimers further increased the breadth and potency of the NAb response. EM based polyclonal epitope mapping revealed that a cross reactive CD4 binding-site (CD4bs) antibody response, that was present after priming with the monovalent trimer and boosting with the trivalent combination, was most likely responsible for the broad neutralization. While anecdotal, this study provides proof-of-concept that native-like Env trimers are capable of inducing CD4bs-directed bNAb responses and should guide efforts to improve the consistency with which such responses are generated.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Differential recognition of computationally optimized H3 hemagglutinin influenza vaccine candidates by human antibodies 96%
- A monoclonal antibody targeting the Nipah virus fusion glycoprotein apex imparts protection from disease 96%
- Optimizing the live attenuated influenza A vaccine backbone for high-risk patient groups 96%
Similar papers in this journal
- Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariants 97%
- Signatures of omicron-like adaptation in early SARS-CoV-2 variants and chronic infection 96%
- Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift 96%
Similar papers in this journal
Similar papers in this journal
- Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques 97%
- Immunogenicity, safety and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs 96%
- Neutralizing antibodies elicited in sequentially immunized macaques recognize V3 residues on altered conformations of HIV-1 Env trimer 96%
Similar papers in this journal
- Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice 97%
- Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates 97%
- A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 delta variant 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.